Canada Spends Logo

Explore our Budget 2026 analysis

Contribution

EUPRAXIA PHARMACEUTICALS INC.

$340,000.00

EF 2014-15 · 2014-04-29

Résumé
To support a firm in the Pharmaceutical and medicine manufacturing (NAICS: 325410) with a research and development project
Programme
—
Emplacement
Victoria, British Columbia|Victoria, Colombie-Britannique, Canada
Type
Contribution
Source
Proactive Disclosure - Grants and Contributions

Tel que publié

Additional Information
Award spanning more than one fiscal year. Original reporting period: 2014-2015 - 3rd quarter
Additional Information (French)
Octroi s'appliquant à plus d'un exercice. Trimestre de divulgation originale: 2014-2015 - 3ième trimestre
Agreement Start Date
2014-04-29
Agreement Type
Contribution
Agreement Value
$340,000.00
Amendment Number
0
Organization Code
nrc-cnrc
Organization
National Research Council Canada | Conseil national de recherches Canada
Program Purpose
To support a firm in the Pharmaceutical and medicine manufacturing (NAICS: 325410) with a research and development project
Program Purpose (French)
Pour supporter une compagnie dans le secteur Fabrication de produits pharmaceutiques et de médicaments (SCIAN: 325410) dans un projet de recherche et développment
Recipient City
Victoria, British Columbia|Victoria, Colombie-Britannique
Recipient Country
CA
Recipient Legal Name
EUPRAXIA PHARMACEUTICALS INC.
Reference Number
GC-2015-Q2-27718